Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106

STAR: ultrafast universal RNA-seq aligner

Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259

Clinical characteristics of coronavirus disease 2019 in China

Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246

featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969

Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415

Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China

Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148

La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19

Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463

Neutrophils are gatekeepers of mucosal immunity

Silva, L. M., Kim, T. S., & Moutsopoulos, N. M. (2022) · Immunological Reviews · doi:10.1111/imr.13171 · Cited by 41

The HN protein of Newcastle disease virus induces cell apoptosis through the induction of lysosomal membrane permeabilization

Chen, Y., Zhu, S., Liao, T., Wang, C., Han, J., Yang, Z., Lu, X., Hu, Z., Hu, J., Wang, X., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011981 · Cited by 42

How do we share data in COVID-19 research? A systematic review of COVID-19 datasets in PubMed Central Articles

Zuo, X., Chen, Y., Lucila Ohno-machado, A., & Xu, H. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa331 · Cited by 41

On the genetics and immunopathogenesis of COVID-19

Jacob, C. O. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108591 · Cited by 39

Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes)

Gusev, E., Sarapultsev, A., Hu, D., & Черешнев, В. А. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147582 · Cited by 42

Natural Killer cells in COVID-19: from Infection, to Vaccination and Therapy

Zafarani, A., Razizadeh, M. H., Pashangzadeh, S., Amirzargar, M. R., Taghavi-Farahabadi, M., & Mahmoudi, M. (2023) · Future Virology · doi:10.2217/fvl-2022-0040 · Cited by 43

Viral reactivations and co-infections in COVID-19 patients: a systematic review

Kim, J. Y. H., Ragusa, M. A., Tortosa, F. G., Torres, A., Gresh, L., Mendez-Rico, J. A., Álvarez, C., Lisboa, T. C., Valderrama, S., Aldighieri, S., et al. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08117-y · Cited by 39

Clinical Use of Short-Course and Low-Dose Corticosteroids in Patients With Non-severe COVID-19 During Pneumonia Progression

Hu, Z., Lv, Y., Xu, C., Sun, W., Chen, W., Peng, Z., Chen, C., Cui, X., Jiao, D., Cheng, C., et al. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00355 · Cited by 39

Candesartan could ameliorate the COVID-19 cytokine storm

ELKAHLOUN, A. G., & Saavedra, J. M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110653 · Cited by 40

Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy

Hong, R., Zhao, H., Wang, Y., Chen, Y., Cai, H., Hu, Y., Wei, G., & Huang, H. (2020) · Bone Marrow Transplantation · doi:10.1038/s41409-020-01060-5 · Cited by 41

Differential Expression of Viral Transcripts From Single-Cell RNA Sequencing of Moderate and Severe COVID-19 Patients and Its Implications for Case Severity

Liu, T., Jia, P., Fang, B., & Zhao, Z. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.603509 · Cited by 38

SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets

Li, Y., Duche, A., Sayer, M. R., Roosan, D., Khalafalla, F. G., Ostrom, R. S., Totonchy, J. E., & Roosan, M. R. (2021) · BMC Genomics · doi:10.1186/s12864-021-07433-4 · Cited by 47

mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection

Mukherjee, S., Banerjee, B., Karasik, D., & Frenkel‐Morgenstern, M. (2021) · Viruses · doi:10.3390/v13030402 · Cited by 38

In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors

Laha, S., Saha, C., Dutta, S., Basu, M., Chatterjee, R., Ghosh, S. K., & Bhattacharyya, N. P. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06395 · Cited by 42

Digital technologies in micro and small enterprise: evidence from Uganda's informal sector during the COVID-19 pandemic

Kimuli, S. N. L., Sendawula, K., & Nagujja, S. (2021) · World Journal of Science Technology and Sustainable Development · doi:10.1108/wjstsd-02-2021-0017 · Cited by 44

RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes

Meng, Y., Zhang, Q., Wang, K., Zhang, X., Yang, R., Bi, K., Chen, W., & Diao, H. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04012-z · Cited by 43

Single-cell analysis of severe COVID-19 patients reveals a monocyte-driven inflammatory storm attenuated by TocilizumabPreprint

Guo, C., Li, B., Ma, H., Wang, X., Cai, P., Yu, Q., Zhu, L., Jin, L., Jiang, C., Fang, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.08.029769 · Cited by 42

COVID-19 Immunobiology: Lessons Learned, New Questions Arise

Kaklamanos, A., Belogiannis, K., Skendros, P., Gorgoulis, V. G., Vlachoyiannopoulos, P. G., & Tzioufas, A. G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.719023 · Cited by 37

Remdesivir: A beacon of hope from Ebola virus disease to COVID ‐19

Nili, A., Farbod, A., Neishabouri, A., Mozafarihashjin, M., Tavakolpour, S., & Mahmoudi, H. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2133 · Cited by 39

MAFB and MAF Transcription Factors as Macrophage Checkpoints for COVID-19 Severity

Vega, M. A., Simón‐Fuentes, M., de la Aleja, A. G., Nieto, C., Colmenares, M., Herrero, C., Domínguez‐Soto, Á., & Corbí, A. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.603507 · Cited by 37

IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA

Zheng, Q., Wang, D., Lin, R., Lv, Q., & Wang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1013322 · Cited by 38

Similarities between COVID-19 and systemic sclerosis early vasculopathy: A “viral” challenge for future research in scleroderma

Matucci‐Cerinic, M., Hughes, M., Taliani, G., & Kahaleh, B. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102899 · Cited by 37

SARS-CoV-2 Nsp8 suppresses MDA5 antiviral immune responses by impairing TRIM4-mediated K63-linked polyubiquitination

Zhang, X., Yang, Z., Pan, T. S., Sun, Q., Chen, Q., Wang, P., Li, X., & Kuang, E. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011792 · Cited by 37

Vascular Alterations Following COVID-19 Infection: A Comprehensive Literature Review

Karakasis, P., Nasoufidou, A., Sagris, Μ., Fragakis, N., & Tsioufis, K. P. (2024) · Life · doi:10.3390/life14050545 · Cited by 37

SARS‐CoV ‐2 multifaceted interaction with the human host. Part II : Innate immunity response, immunopathology, and epigenetics

Beacon, T. H., Su, R., Lakowski, T. M., Delcuve, G. P., & Davie, J. (2020) · IUBMB Life · doi:10.1002/iub.2379 · Cited by 38

SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments

Canedo-Marroquín, G., Saavedra, F., Andrade, C. A., Berríos-Rojas, R. V., Rodríguez‐Guilarte, L., Opazo, M. C., Riedel, C. A., & Kalergis, A. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.569760 · Cited by 40

An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19

Wang, J. Y., Zhang, W., Roehrl, M. H. A., Roehrl, V. B., & Roehrl, M. H. A. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102644 · Cited by 37

IL-33 in COVID-19: friend or foe?

Liang, Y., Ge, Y., & Sun, J. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00685-w · Cited by 38

Bioinformatics and system biology approaches to identify pathophysiological impact of COVID-19 to the progression and severity of neurological diseases

Rahman, M. H., Rana, H. K., Peng, S., Kibria, M. G., Islam, M. Z., Mahmud, S. M. H., & Moni, M. A. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104859 · Cited by 37

Impact of computational approaches in the fight against COVID-19: an AI guided review of 17 000 studies

Napolitano, F., Xu, X., & Gao, X. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab456 · Cited by 37

Immune response to SARS-CoV-2 variants: A focus on severity, susceptibility, and preexisting immunity

Alefishat, E. A., Jelinek, H. F., Mousa, M., Tay, G. K., & AlSafar, H. S. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.01.007 · Cited by 39

Circadian rhythm disruption in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for the post-acute sequelae of COVID-19

McCarthy, M. J. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100412 · Cited by 37

Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine

Furuyama, W., Shifflett, K., Pinski, A. N., Griffin, A. J., Feldmann, F., Okumura, A., Gourdine, T., Jankeel, A., Lovaglio, J., Hanley, P. W., et al. (2022) · mBio · doi:10.1128/mbio.03379-21 · Cited by 39

Abnormal global alternative RNA splicing in COVID-19 patients

Wang, C., Chen, L., Chen, Y., Jia, W., Cai, X., Liu, Y., Ji, F., Peng, X., Liang, A., Liu, R., et al. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010137 · Cited by 39

SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity

Zhang, W., Chua, B. Y. L., Selva, K. J., Kedzierski, Ł., Ashhurst, T. M., Haycroft, E. R., Shoffner, S. K., Hensen, L., Boyd, D. F., James, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30088-y · Cited by 39

E-cigarettes and youth: an unresolved Public Health concern

Virgili, F., Nenna, R., David, S. B., Mancino, E., Mattia, G. D., Matera, L., Petrarca, L., & Midulla, F. (2022) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-022-01286-7 · Cited by 43

Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquer

Batiha, G. E., Al-Gareeb, A. I., Rotimi, D., Adeyemı, O. S., & Al-Kuraishy, H. M. (2022) · Scientific African · doi:10.1016/j.sciaf.2022.e01407 · Cited by 36

Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences

Aiello, A., Fard, S. N., & Goletti, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1244556 · Cited by 38

Encephalitic syndrome and anosmia in COVID‐19: Do these clinical presentations really reflect SARS‐CoV‐2 neurotropism? A theory based on the review of 25 COVID‐19 cases

Pouga, L. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26309 · Cited by 34

CXCR3-Expressing T Cells in Infections and Autoimmunity

Rubinstein, A., Kudryavtsev, I. V., Arsentieva, N. A., Korobova, Z. R., Isakov, D., & Тотолян, А. А. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2908301 · Cited by 42

Macrophage responses associated with COVID-19: A pharmacological perspective

Booz, G. W., Altara, R., Eid, A. H., Wehbe, Z., Fares, S. A., Zaraket, H., Habeichi, N. J., & Zouein, F. A. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173547 · Cited by 38

Can Natural Killer Cells Be a Principal Player in Anti-SARS-CoV-2 Immunity?

Ahmed, F. N., Jo, D., & Lee, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.586765 · Cited by 36

RGD‐binding integrins and TGF‐β in SARS‐CoV‐2 infections – novel targets to treat COVID‐19 patients?

Carvacho, I., & Piesche, M. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1240 · Cited by 36

Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19–Associated Coagulopathies

FitzGerald, E. S., Chen, Y., Fitzgerald, K. A., & Jamieson, A. M. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0453oc · Cited by 35

Differential host circRNA expression profiles in human lung epithelial cells infected with SARS-CoV-2

Yang, M., Qi, M., Xu, L., Huang, P., Wang, X., Sun, J., Shi, J., & Hu, Y. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104923 · Cited by 34

Transcriptome-based drug repositioning for coronavirus disease 2019 (COVID-19)

Jia, Z., Song, X., Shi, J., Wang, W., & He, K. (2020) · Pathogens and Disease · doi:10.1093/femspd/ftaa036 · Cited by 34

COVID-19: Brief check through the pathologist's eye (autopsy archive)

Mansueto, G. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.153195 · Cited by 33

Distinct Mitochondria-Mediated T-Cell Apoptosis Responses in Children and Adults With Coronavirus Disease 2019

Yang, Y., Kuang, L., Li, L., Wu, Y., Zhong, B., & Huang, X. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab400 · Cited by 34

Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis

Crespo‐Facorro, B., Ruíz-Veguilla, M., Vázquez-Bourgón, J., Sánchez-Hidalgo, A. C., Torres, N. G., Cisneros, J. M., Prieto, C. A. V., & Sainz, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.646701 · Cited by 34

Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury

Chen, J., Wang, W., Tang, Y., Huang, X., Yu, X., & Lan, H.-Y. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.58791 · Cited by 37

Predicting COVID-19—Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management

Barh, D., Aljabali, A. A. A., Tambuwala, M. M., Tiwari, S., Serrano‐Aroca, Á., Alzahrani, K. J., Andrade, B. S., Azevedo, V., Ganguly, N. K., & Lundstrom, K. H. (2021) · Biomedicines · doi:10.3390/biomedicines9050556 · Cited by 35

Innate Immune Response in SARS-CoV-2 Infection

Schiuma, G., Beltrami, S., Bortolotti, D., Rizzo, S., & Rizzo, R. (2022) · Microorganisms · doi:10.3390/microorganisms10030501 · Cited by 39

The role of antigen-presenting cells in the pathogenesis of COVID-19

Farzi, R., Aghbash, P. S., Eslami, N., Azadi, A., Shamekh, A., Hemmat, N., Entezari‐Maleki, T., & Baghi, H. B. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153848 · Cited by 33

Cytokines and microRNAs in SARS-CoV-2: What do we know?

Rarani, F. Z., Rashidi, B., Abadi, M. H. J. N., Hamblin, M. R., Hashemian, S. M. R., & Mirzaei, H. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.06.017 · Cited by 35

Mitochondrial-targeted ubiquinone: A potential treatment for COVID-19

Ouyang, L., & Gong, J. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110161 · Cited by 33

The Pathophysiology, Diagnosis and Treatment of Corona Virus Disease 2019 (COVID-19)

Das, S. K. (2020) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-020-00919-0 · Cited by 33

Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses

O’Connell, P., & Aldhamen, Y. A. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1802974 · Cited by 34

Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis

Zhang, C., Feng, Y., Tam, C., Wang, N., & Feng, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.733171 · Cited by 33

Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS

García‐Hidalgo, M. C., González, J., Benitez, I. D., Carmona, P., Santisteve, S., Perez‐Pons, M., Moncusí‐Moix, A., Gort‐Paniello, C., Rodríguez‐Jara, F., Molinero, M., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2081615 · Cited by 33

LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIALPreprint

Temesgen, Z., Burger, C. D., Baker, J. V., Polk, C. M., Libertin, C. R., Kelley, C. F., Marconi, V. C., Orenstein, R., Durrant, C., Chappell, D. B., et al. (2021) · medRxiv · doi:10.1101/2021.05.01.21256470 · Cited by 32

Identification of COVID-19 and Dengue Host Factor Interaction Networks Based on Integrative Bioinformatics Analyses

Zheng, W., Wu, H. M., Liu, C., Yan, Q., Wang, T., Wu, P., Liu, X., Jiang, Y., & Zhan, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.707287 · Cited by 32

Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes

Zhang, Y., Bharathi, V., Dokoshi, T., de Anda, J., Ursery, L., Kulkarni, N. N., Nakamura, Y., Chen, J., Luo, E. W.-C., Wang, L., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2300644120 · Cited by 33

In silico and in vitro studies reveal complement system drives coagulation cascade in SARS-CoV-2 pathogenesis

Tiwari, R., Mishra, A., Mikaeloff, F., Gupta, S., Mirazimi, A., Byrareddy, S. N., Neogi, U., & Nayak, D. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.11.005 · Cited by 32

A review of COVID-19 biomarkers and drug targets: resources and tools

Caruso, F. P., Scala, G., Cerulo, L., & Ceccarelli, M. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa328 · Cited by 35

Natural Polyphenols as Immunomodulators to Rescue Immune Response Homeostasis: Quercetin as a Research Model against Severe COVID-19

Bernini, R., & Velotti, F. (2021) · Molecules · doi:10.3390/molecules26195803 · Cited by 32

MicroRNAs based regulation of cytokine regulating immune expressed genes and their transcription factors in COVID-19

Khokhar, M., Tomo, S., & Purohit, P. (2021) · Meta Gene · doi:10.1016/j.mgene.2021.100990 · Cited by 35

An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19

Wang, J. Y., Zhang, W., Roehrl, M. H. A., Roehrl, M. H. A., & Roehrl, M. H. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.831849 · Cited by 32

SARS-CoV-2 niches in human placenta revealed by spatial transcriptomics

Barrozo, E. R., Seferovic, M. D., Castro, E. C. C., Major, A. M., Moorshead, D., Jochum, M. D., Rojas, R., Shope, C. D., & Aagaard, K. M. (2023) · Med · doi:10.1016/j.medj.2023.06.003 · Cited by 34

HLA predictions from the bronchoalveolar lavage fluid and blood samples of eight COVID-19 patients at the pandemic onset

Warren, R. L., & Birol, İ. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa756 · Cited by 31

Transcriptome Analysis of Peripheral Blood Mononuclear Cells Reveals Distinct Immune Response in Asymptomatic and Re-Detectable Positive COVID-19 Patients

Zhang, J., Lin, D., Li, K., Ding, X., Li, L., Liu, Y., Liu, D., Lin, J., Teng, X., Li, Y., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.716075 · Cited by 31

Epitranscriptomic m 5 C methylation of SARS-CoV-2 RNA regulates viral replication and the virulence of progeny viruses in the new infection

Wang, H., Feng, J., Fu, Z., Xu, T., Liu, J., Yang, S., Li, Y., Deng, J., Zhang, Y., Guo, M. S., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn9519 · Cited by 31

Cell‐mediated immunity to SARS‐CoV‐2

Wang, X., & Gui, J. (2020) · Pediatric Investigation · doi:10.1002/ped4.12228 · Cited by 32

Severe COVID-19: Immunosuppression or Hyperinflammation?

Liu, Y., Li, Y., Xu, D., Zhang, J., & Peng, Z. (2021) · Shock · doi:10.1097/shk.0000000000001724 · Cited by 33

VB10, a new blood biomarker for differential diagnosis and recovery monitoring of acute viral and bacterial infections

Ravichandran, S., Banerjee, U., Devi, G., Kandukuru, R., Thakur, C., Chakravortty, D., Balaji, K. N., Singh, A., & Chandra, N. R. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103352 · Cited by 30

The Immunological Role of the Placenta in SARS-CoV-2 Infection—Viral Transmission, Immune Regulation, and Lactoferrin Activity

Bukowska‐Ośko, I., Popiel, M., & Kowalczyk, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115799 · Cited by 32

Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches

Hoque, M. N., Sarkar, M. M. H., Khan, M. A., Hossain, M. A., Hasan, M. I., Rahman, M. H., Habib, M. A., Akter, S., Banu, T. A., Goswami, B., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.918692 · Cited by 32

Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?

Quan, Y., Li, L., Yin, Z., Chen, S., Yi, J., Lang, J., Zhang, L., Yue, Q., & Zhao, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.784335 · Cited by 30

Recent trends on omics and bioinformatics approaches to study SARS-CoV-2: A bibliometric analysis and mini-review

Murillo, J., Villegas-Trujillo, L. M., Ulloa-Murillo, L. M., & Rodríguez, A. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.104162 · Cited by 31

Gene expression profiling of SARS-CoV-2 infections reveal distinct primary lung cell and systemic immune infection responses that identify pathways relevant in COVID-19 disease

Moni, M. A., Quinn, J. M. W., Sinmaz, N., & Summers, M. A. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa376 · Cited by 30

Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling

Xi, X., Guo, Y., Zhu, M., Wei, Y., Li, G., Du, B., & Wang, Y. (2021) · Virology Journal · doi:10.1186/s12985-020-01478-9 · Cited by 30

Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19

Tan, Y., Zhang, W., Zhu, Z., Qiao, N., Ling, Y., Guo, M., Tong, Y., Fang, H., Xu, X., Lü, G., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00274-1 · Cited by 29

Evaluation of expression of VDR-associated lncRNAs in COVID-19 patients

Taheri, M. N., Rad, L. M., Hussen, B. M., Nicknafs, F., Sayad, A., & Ghafouri‐Fard, S. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06248-8 · Cited by 30

Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis

Rahman, M. R., Islam, T., Shahjaman, M., Islam, M. R., Lombardo, S. D., Bramanti, P., Ciurleo, R., Bramanti, A., Tchorbanov, A. I., Fisicaro, F., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab262 · Cited by 31

Clinical progress in MSC-based therapies for the management of severe COVID-19

Rossello-Gelabert, M., Gonzalez‐Pujana, A., Igartúa, M., Santos‐Vizcaíno, E., & Hernández, R. M. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.07.002 · Cited by 30

Interplay of LncRNAs NEAT1 and TUG1 in Incidence of Cytokine Storm in Appraisal of COVID-19 Infection

Tayel, S. I., El-Masry, E. A., Abdelaal, G. A., Shehab-Eldeen, S., Essa, A. S., & Muharram, N. M. M. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72318 · Cited by 30

Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe coronavirus 2019 (COVID-19) disease

Girard, T., Antunes, L., Zhang, N., Amrute, J., Subramanian, R., Eldem, İ., Remy, K. E., Mazer, M. B., Erlich, E. C., Cruchaga, C., et al. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2022.11.033 · Cited by 30

Molecular Alterations Prompted by SARS-CoV-2 Infection: Induction of Hyaluronan, Glycosaminoglycan and Mucopolysaccharide Metabolism

Andonegui-Elguera, S., Taniguchi‐Ponciano, K., González-Bonilla, C. R., Torres, J., Mayani, H., Herrera, L. A., Peña-Martínez, E., Silva-Román, G., Vela-Patiño, S., Ferreira‐Hermosillo, A., et al. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.06.011 · Cited by 29

Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients

Aliter, K. F., & Al‐Horani, R. A. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201001125604 · Cited by 30

Is lymphopenia different between SARS and COVID‐19 patients?

Yan, S., & Wu, G. (2021) · The FASEB Journal · doi:10.1096/fj.202002512 · Cited by 28

Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study

Dauletova, M., Hafsan, H., Mahhengam, N., Zekiy, A. O., Ahmadi, M., & Siahmansouri, H. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108712 · Cited by 29

COVID-19 patient transcriptomic and genomic profiling reveals comorbidity interactions with psychiatric disorders

Moni, M. A., Lin, P., Quinn, J. M. W., & Eapen, V. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01151-3 · Cited by 30

Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19

Julià, A., Bonafonte-Pardàs, I., Gómez, A., Lasanta, M. L., López-Corbeto, M., Martínez-Mateu, S. H., Lladós, J., Rodríguez-Nunez, I., Myers, R., & Marsal, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-90797-0 · Cited by 30

Interplay between hypoxia and inflammation contributes to the progression and severity of respiratory viral diseases

Bhattacharya, S., Agarwal, S., Shrimali, N. M., & Guchhait, P. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101000 · Cited by 33

A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels

Kleymenov, D. A., Bykonia, E. N., Popova, L. I., Mazunina, E. P., Gushchin, V. А., Колобухина, Л. В., Burgasova, O., Kruzhkova, I. S., Kuznetsova, N. A., Shidlovskaya, E. V., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.771609 · Cited by 30

Oral Hsp90 inhibitor SNX-5422 attenuates SARS-CoV-2 replication and dampens inflammation in airway cells

Goswami, R., Russell, V. S., Tu, J. J., Thomas, C., Hughes, P. F., Kelly, F. L., Langel, S. N., Steppe, J. T., Palmer, S. M., Haystead, T., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103412 · Cited by 28

Understanding Gene Expression and Transcriptome Profiling of COVID-19: An Initiative Towards the Mapping of Protective Immunity Genes Against SARS-CoV-2 Infection

Chakraborty, C., Sharma, A. R., Bhattacharya, M., Zayed, H., & Lee, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.724936 · Cited by 29

Citicoline and COVID-19-Related Cognitive and Other Neurologic Complications

Turana, Y., Nathaniel, M., Shen, R., Ali, S., & Aparasu, R. R. (2021) · Brain Sciences · doi:10.3390/brainsci12010059 · Cited by 33

Genetic and Clinical Characteristics of Patients in the Middle East With Multisystem Inflammatory Syndrome in Children

Abuhammour, W., Yavuz, L., Jain, R., Hammour, K. A., Al-Hammouri, G. F., Naofal, M. E., Halabi, N., Yaslam, S., Ramaswamy, S., Taylor, A., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.14985 · Cited by 29

COVID-19: The Emerging Immunopathological Determinants for Recovery or Death

Ahmad, T., Chaudhuri, R., Joshi, M. C., Almatroudi, A., Rahmani, A. H., & Ali, S. M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.588409 · Cited by 30

Transcriptomic analysis of COVID‑19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection

Cavalli, E., Petralia, M. C., Basile, M. S., Bramanti, A., Bramanti, P., Nicoletti, F., Spandidos, D. A., Shoenfeld, Y., & Fagone, P. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4702 · Cited by 37

Transcriptomic dysregulations associated with SARS-CoV-2 infection in human nasopharyngeal and peripheral blood mononuclear cellsPreprint

de Melo, C. V. B., Bhuiyan, M. A., Gatua, W., Kanyerezi, S., Uzairue, L. I., Abechi, P., Kumar, K., Rahmat, J., Giwa, A. O., Mwandira, G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.09.289850 · Cited by 2

Immune transcriptomic analysis on COVID-19 patients with varying clinical presentations identifies severity markers

Abdallah, A. M., Ansari, H., Shuaib, M., Doudin, A., Yassine, H. M., Shah, S. S. U. D., Mir, F., Emara, M., Elzouki, A.-N., & Cyprian, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-04837-0 · Cited by 1

Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients

Zhou, Z. L., Ren, L., Zhang, L., Zhong, J., Xiao, Y., Jia, Z., Guo, L., Yang, J., Wang, C., Jiang, S., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.017 · Cited by 980

Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse

Gardinassi, L. G., Souza, C. O. S., Sales‐Campos, H., & Fonseca, S. G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01636 · Cited by 112